Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells

被引:58
作者
Nakamura, M
Gotoh, T
Okuno, Y
Tatetsu, H
Sonoki, T
Uneda, S
Mori, M
Mitsuya, H
Hata, H
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608556, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Hematol, Kumamoto 8608556, Japan
关键词
multiple myeloma; endoplasmic reticulum stress; apoptosis; XBP-1;
D O I
10.1080/10428190500312196
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The endoplasmic reticulum (ER) is an organelle in which proteins are modified. When unfolded proteins accumulate in the ER under various stresses, ER stress (ERS) pathways, including the induction of chaperones, are activated to protect the cell. However, when ERS is excessive, the cell undergoes apoptosis. This study investigated ERS in multiple myeloma cells (MMCs) because they contain a well-developed ER due to M-protein production. The myeloma cell line 12-PE underwent apoptosis via caspase-3 after treatment with thapsigargin (thap), an ERS inducer, while another cell line, U266, did not. To understand the mechanism regulating this heterogeneity, the induction of chaperones by thap was analysed. Chaperones were up-regulated in U266 cells but down-regulated in 12-PE cells, suggesting that chaperones contribute to cell survival under ERS. Analysis of XBP-1, a transcriptional inducer of chaperones, in freshly isolated MMCs from 22 myeloma cases revealed 10 cases with active XBP-1, who also showed significantly poorer survival (p < 0.05), suggesting that chaperone expression protects MMCs from apoptosis, thereby allowing tumor cell expansion. These results suggest that MMCs are subjected to ERS under certain circumstances and that chaperones are induced to protect the cells against such ERS. Inhibition of chaperones could be a new target for myeloma therapy.
引用
收藏
页码:531 / 539
页数:9
相关论文
共 43 条
[1]   Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: Identification of prognostic factors [J].
Anagnostopoulos, A ;
Gika, D ;
Hamilos, G ;
Zervas, K ;
Zomas, A ;
Pouli, A ;
Zorzou, M ;
Kastritis, E ;
Anagnostopoulos, N ;
Tassidou, A ;
Anagnostou, D ;
Dimopoulos, MA .
LEUKEMIA & LYMPHOMA, 2004, 45 (11) :2275-2279
[2]   Tetrocarcin-A-induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2-independent pathway [J].
Anether, G ;
Tinhofer, I ;
Senfter, M ;
Greil, R .
BLOOD, 2003, 101 (11) :4561-4568
[3]   IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA [J].
Calfon, M ;
Zeng, HQ ;
Urano, F ;
Till, JH ;
Hubbard, SR ;
Harding, HP ;
Clark, SG ;
Ron, D .
NATURE, 2002, 415 (6867) :92-96
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   TERMINAL DIFFERENTIATION OF HUMAN PROMYELOCYTIC LEUKEMIA-CELLS INDUCED BY DIMETHYL-SULFOXIDE AND OTHER POLAR COMPOUNDS [J].
COLLINS, SJ ;
RUSCETTI, FW ;
GALLAGHER, RE ;
GALLO, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (05) :2458-2462
[6]  
DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO
[7]  
2-U
[8]  
EPSTEIN MA, 1966, J NATL CANCER I, V37, P547
[9]   Organelle-specific initiation of cell death pathways [J].
Ferri, KF ;
Kroemer, G .
NATURE CELL BIOLOGY, 2001, 3 (11) :E255-E263
[10]   Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells [J].
Gotoh, T ;
Mori, M .
JOURNAL OF CELL BIOLOGY, 1999, 144 (03) :427-434